BELGIUM - Gilde portfolio company Ablynx raises EUR 75m in Euronext Brussels

Gilde portfolio company Ablynx has raised EUR 75m in the largest biotech IPO on Euronext Brussels. The IPO was priced at EUR 7 per share. Pursuant to the offering, 10,714,285 new shares, equivalent to EUR 75m will be issued by Ablynx, and additionally, 1,607,142 over-allotment shares, equivalent to EUR11.25m will be allocated. If the over-allotment option is exercised in full, the total amount of the capital increase will amount to EUR 86.25m.